IMC Bringing Israeli Expertise
Into a Global Market

A Pharma Grade Medical Cannabis Brand Capturing
The Full Value Chain at Higher Margins

Play Video

Financial Overview

$1,644.89 Feb 12, 2019
Valuation at IPO $52.7B
IPO Share Price CAD$4
Founded Date2010
FoundersOren Shuster & Rafael Gabay
Number of Employees50
CSE SymbolIMCC

Funding Rounds

2 Funding Rounds

C$ 29.5M Total Funding Amount

Funding Rounds
2019 Private PlacementsC$ 20,400,000
2018 Private PlacementsC$ 9,131,000

Investments

Investments

Total Investments Amount

Upcoming Events

IM Cannabis to Present at PI Financial Conference in London

London, England I November 18, 2019

IACM

Berlin, Germany I October 31 till November 2, 2019

CPhI

Frankfurt, Germany I November 5 till November 7, 2019

View All Events

CSE Reports

q22019Quarterly Financial Statements Q2/2019
q12019Quarterly Financial Statements Q1/2019
annual-2018Annual Financial Statements 2018
See All Reports

Corporate Presentations

Corporate PresentationNovember 2019
See All Presentions

News and Updates

December 1, 2019

Full interview: IM Cannabis eyes the European medical cannabis market as it lists on the CSE

November 5, 2019

IM Cannabis to Become First Israeli Medical Cannabis Operator to List on CSE

April 29, 2019

Israel New Cannabis Reform has Begun

View All News

Technology and Innovation

Our Technology Innovation

IMC is one of the world & the most advanced cannabis cultivators. Utilizing a decade of cannabis growing.....

Read More